ARQT Sale Disclosure
Burnett Patrick · SEC Form 4 · Filed Nov 4, 2026
Sale
Calculated transaction value
$30.05K
Burnett Patrick EVP, Chief Medical Officer
ARQT
Transaction date
Nov 2, 2026
Public filing date
Nov 4, 2026
Filing lag
Filed 2 days later
ARQT daily price context
Close on/before transaction
$31.26
Nov 2, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 943 shares @ $31.86
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001628280-26-070383
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$30.05K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Arcutis Biotherapeutics, Inc. ARQT Current | Sale | Nov 2, 2026 | $30.05K |